Waning immunity against mumps in vaccinated young adults, France 2013

Eurosurveillance

Volumn 21, Issue 10, 2016, Pages

  Vygen, Sabine ^a,b   Fischer, A ^a,b   Meurice, L ^a   Mounchetrou Njoya, I ^c   Gregoris, M ^d   Ndiaye, B ^c   Ghenassia, A ^c   Poujol, I ^e   Stahl, J P ^f   Antona, D ^g   Le Strat, Y ^g   Levy Bruhl, D ^g   Rolland, P ^a  

^a French Institute for Public Health Surveillance InVS   (France)

^b European Centre for Disease Prevention and Control (ECDC)   (France)

^c InVS   (France)

^d Regional health authority (ARS)   (France)

^e Regional office Rhône Alpes   (France)

^f HÔPITAL MICHALLON   (France)

^g InVS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE; MUMPS VACCINE;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; FRANCE; HUMAN; INFECTION CONTROL; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MUMPS; ORCHITIS; PAROTITIS; POLYMERASE CHAIN REACTION; QUESTIONNAIRE; SIALOADENITIS; VACCINATION; YOUNG ADULT; ADOLESCENT; DISEASE NOTIFICATION; EPIDEMIC; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; MUMPS VIRUS; STATISTICS AND NUMERICAL DATA; STUDENT;

ADOLESCENT; CASE-CONTROL STUDIES; DISEASE NOTIFICATION; DISEASE OUTBREAKS; FEMALE; FRANCE; HUMANS; MALE; MEASLES-MUMPS-RUBELLA VACCINE; MUMPS; MUMPS VACCINE; MUMPS VIRUS; STUDENTS; SURVEYS AND QUESTIONNAIRES; VACCINATION; YOUNG ADULT;

EID: 84960830921     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.ES.2016.21.10.30156     Document Type: Article

References (33)

1. Institut de Veille Sanitaire (InVS). Dossiers thématiques; Oreillons. [Thematic dossiers; mumps]. French. [Accessed 15 Jul 2013]. Available from: http://www.invs.sante.fr/Dossiers-thematiques/Maladies-infectieuses/Maladies-a-prevention-vaccinale/Oreillons
2. Coffinières E, Turbelin C, Riblier D, Aouba A, Levy-Bruhl D, Arena C, et al. Mumps: burden of disease in France. Vaccine. 2012;30(49):7013-8. DOI: 10.1016/j.vaccine.2012.09.070 PMID: 23059354
3. Nelson GE, Aguon A, Valencia E, Oliva R, Guerrero ML, Reyes R, et al. Epidemiology of a mumps outbreak in a highly vaccinated island population and use of a third dose of measles-mumps-rubella vaccine for outbreak control--Guam 2009 to 2010. Pediatr Infect Dis J. 2013;32(4):374-80. DOI: 10.1097/INF.0b013e318279f593 PMID: 23099425
4. Institut national de prévention et d’éducation pour la santé (Inpes), Paris, France. Vaccination contre les oreillons, dans Guide des vaccinations - Edition 2012, page 223-229. [Vaccination against mumps, in the guide to vaccinations–edition 2012, pp. 142-8]. Paris: Inpes; 2012. French. Available from: http://www.inpes.sante.fr/10000/themes/vaccination/guide-vaccination-2012/pdf/GuideVaccinations2012_Vaccination_contre_les_oreillons.pdf
5. Le calendrier des vaccinations et les recommandations vaccinales 1996-1997. [Vaccination calendar and vaccination recommendations 1996-1997]. Bull Epidemiol Hebd. 1996; 35: 151-3. French. Available from: http://www.invs.sante.fr/beh/1996/9635/index.html
6. Institut de Veille Sanitaire. Comité technique des vaccinations, Paris, France. Calendrier des vaccinations et les recommandations vaccinales 2013 selon l’avis du Haut conseil de la santé publique. [Vaccination calendar and vaccination recommendations for 2013 according to the opinion of the High council of public health]. Bull Epidemiol Hebd 2013;14-15. French. Available from: http://www.invs.sante.fr/Publicationset-outils/BEH-Bulletin-epidemiologique-hebdomadaire/Archives/2013/BEH-n-14-15-2013
7. Antona D, Fonteneau L, Lévy-Bruhl D, Guignon N, De Peretti C, Niel X, et al. Couverture vaccinale des enfants et des adolescents en France: résultats des enquêtes menées en milieu scolaire, 2001-2004. [Vaccination coverage of children and adolescents in France: results of a school survey, 2001- 2014]. Bull Epidemiol Hebd 2007;6:45-9. French. Available from: http://www.invs.sante.fr/beh/2007/06/beh_06_2007.pdf
8. The French National Institute of Health and Medical Research (Inserm U707). University of Paris VI: Pierre and Marie Curie, Paris, France. Réseau Sentinelles [French GP sentinel network]. French. [Accessed in June 2013]. Available from: http://websenti.u707.jussieu.fr/sentiweb/?page=bilan
9. Sane J, Gouma S, Koopmans M, de Melker H, Swaan C, van Binnendijk R, et al. Epidemic of mumps among vaccinated persons, The Netherlands, 2009-2012. Emerg Infect Dis. 2014;20(4):643-8. DOI: 10.3201/eid2004.131681 PMID: 24655811
10. Dayan GH, Quinlisk MP, Parker AA, Barskey AE, Harris ML, Schwartz JM, et al. Recent resurgence of mumps in the United States. N Engl J Med. 2008;358(15):1580-9. DOI: 10.1056/NEJMoa0706589 PMID: 18403766
11. Eriksen J, Davidkin I, Kafatos G, Andrews N, Barbara C, Cohen D, et al. Seroepidemiology of mumps in Europe (1996-2008): why do outbreaks occur in highly vaccinated populations? Epidemiol Infect. 2013;141(3):651-66. DOI: 10.1017/S0950268812001136 PMID: 22687578
12. Anis E, Grotto I, Moerman L, Warshavsky B, Slater PE, Lev B. Mumps outbreak in Israel’s highly vaccinated society: are two doses enough? Epidemiol Infect. 2012;140(3):439-46. DOI: 10.1017/S095026881100063X PMID: 21554780
13. Dayan GH, Rubin S. Mumps outbreaks in vaccinated populations: are available mumps vaccines effective enough to prevent outbreaks? Clin Infect Dis. 2008;47(11):1458-67. DOI: 10.1086/591196 PMID: 18959494
14. Yung CF, Andrews N, Bukasa A, Brown KE, Ramsay M. Mumps complications and effects of mumps vaccination, England and Wales, 2002-2006. Emerg Infect Dis. 2011;17(4):661-7, quiz 766. DOI: 10.3201/eid1704.101461 PMID: 21470456
15. Cohen C, White JM, Savage EJ, Glynn JR, Choi Y, Andrews N, et al. Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England. Emerg Infect Dis. 2007;13(1):12-7. DOI: 10.3201/eid1301.060649 PMID: 17370510
16. Marin M, Quinlisk P, Shimabukuro T, Sawhney C, Brown C, Lebaron CW. Mumps vaccination coverage and vaccine effectiveness in a large outbreak among college students-- Iowa, 2006. Vaccine. 2008;26(29-30):3601-7. DOI: 10.1016/j.vaccine.2008.04.075 PMID: 18539365
17. Haut Conseil de la santé publique (HCSP). Avis relatif à la conduite à tenir en case d’épisodes de cas groupés d’oreillons en collectivité. Paris: HCSP; 11 Jul 2013. [Opinion on the conduct to adopt in the face of episodes of clusters of mumps in institutions]. French. Available from: http://www.hcsp.fr/Explore.cgi/avisrapportsdomaine?clefr=364
18. Gee S, O’Flanagan D, Fitzgerald M, Cotter S. Mumps in Ireland, 2004-2008. Euro Surveill. 2008;13(18):18857. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=18857PMID: 18768133
19. Ogbuanu IU, Kutty PK, Hudson JM, Blog D, Abedi GR, Goodell S, et al. Impact of a third dose of measles-mumpsrubella vaccine on a mumps outbreak. Pediatrics. 2012 Dec;130(6):e1567-74. Available from: http://pediatrics.aappublications.org/content/130/6/e1567.full.pdf
20. Rajčević S, Šeguljev Z, Petrovic V, Medić S, Nedelijković J, Milosević V, et al. Ongoing mumps outbreak in Novi Sad, the autonomous province of Vojvodina, Serbia, January to April 2012. Euro Surveill. 2012;17(19):20169.PMID: 22607963
21. Quinlisk MP. Mumps control today. J Infect Dis. 2010;202(5):655-6. DOI: 10.1086/655395 PMID: 20662719
22. Cortese MM, Jordan HT, Curns AT, Quinlan PA, Ens KA, Denning PM, et al. Mumps vaccine performance among university students during a mumps outbreak. Clin Infect Dis. 2008;46(8):1172-80. DOI: 10.1086/529141 PMID: 18444852
23. Gouma S, Sane J, Gijselaar D, Cremer J, Hahné S, Koopmans M, et al. Two major mumps genotype G variants dominated recent mumps outbreaks in the Netherlands (2009-2012). J Gen Virol. 2014;95(Pt 5):1074-82. DOI: 10.1099/vir.0.062943-0 PMID: 24603524
24. Savage E, Ramsay M, White J, Beard S, Lawson H, Hunjan R, et al. Mumps outbreaks across England and Wales in 2004: observational study. BMJ. 2005;330(7500):1119-20. DOI: 10.1136/bmj.330.7500.1119 PMID: 15891227
25. Hahné S, Whelan J, van Binnendijk R, Swaan C, Fanoy E, Boot H, et al. Mumps vaccine effectiveness against orchitis. Emerg Infect Dis. 2012;18(1):191-3. DOI: 10.3201/eid1801.111178 PMID: 22260843
26. Ladbury G, Ostendorf S, Waegemaekers T, van Binnendijk R, Boot H, Hahné S. Smoking and older age associated with mumps in an outbreak in a group of highlyvaccinated individuals attending a youth club party, the Netherlands, 2012. Euro Surveill. 2014;19(16):20776. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20776DOI: 10.2807/1560-7917.ES2014.19.16.20776 PMID: 24786261
27. De Serres G, Boulianne N, Defay F, Brousseau N, Benoît M, Lacoursière S, et al. Higher risk of measles when the first dose of a 2-dose schedule is given at 12-14 versus 15 months of age. Clin Infect Dis. 2012;55(3):394-402. DOI: 10.1093/cid/cis439 PMID: 22543023
28. Hall R, Richards H. Hearing loss due to mumps. Arch Dis Child. 1987;62(2):189-91. DOI: 10.1136/adc.62.2.189 PMID: 3827297
29. Gupta RK, Best J, MacMahon E. Mumps and the UK epidemic 2005. BMJ. 2005;330(7500):1132-5. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC557899/DOI: 10.1136/bmj.330.7500.1132 PMID: 15891229
30. Arday DR, Kanjarpane DD, Kelley PW. Mumps in the US Army 1980-86: should recruits be immunized? Am J Public Health. 1989;79(4):471-4. DOI: 10.2105/AJPH.79.4.471 PMID: 2494895
31. Rubin SA, Plotkin SA. Mumps vaccine. In: Plotkin S, Orenstein W, Offit P, editors. Vaccines. 6th ed. Philadelphia: Saunders; 2012. p. 419-46.
32. Levine H, Rishpon S, Huerta-Hartal M, Davidovitch N. Preventing mumps outbreaks in confined settings: comprehensive ring vaccination as a containment strategy. Hum Vaccin. 2011;7(12):1389-93.Available from: http://www.tandfonline.com/doi/abs/10.4161/hv.7.12.18111DOI: 10.4161/hv.7.12.18111 PMID: 22108037
33. Gouma S, Schurink-Van’t Klooster TM, de Melker HE, Kerkhof J, Smits GP, Hahné SJ, et al. Mumps serum antibody levels before and after an outbreak to assess infection and immunity in vaccinated students. Open Forum Infect Dis. 2014;1(3):ofu101. DOI: 10.1093/ofid/ofu101 PMID: 25734169